Buchang Pharma's Subsidiary to Set Up Joint Venture

MT Newswires Live

Jun 10

Shandong Buchang Pharmaceuticals' (SHA:603858) subsidiary, Shanghai Hepu Medical Technology, agreed to established a joint venture with Sichuan Lindong Enterprise Management Center (Limited Partnership), according to Shanghai bourse filing on Wednesday.

The joint venture company, Sichuan Hepu Tongchuang Medical Technology, will have a registered capital of 4.5 million yuan

Hepu Medical Tech will own 70% of the venture after investing 3.2 million yuan, while Sichuan Lindong will own the remaining 30% after investing 1.4 million yuan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2642441148"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2642441148\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2642441148?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 16:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2642441148","market":"hk","top_or_hot":-1,"title":"Buchang Pharma's Subsidiary to Set Up Joint Venture","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/603858\">Shandong Buchang</a> Pharmaceuticals' (SHA:603858) subsidiary, Shanghai Hepu Medical Technology, agreed to established a joint venture with Sichuan Lindong Enterprise Management Center (Limited Partnership), according to Shanghai bourse filing on Wednesday.</p><p>The joint venture company, Sichuan Hepu Tongchuang Medical Technology, will have a registered capital of 4.5 million yuan</p><p>Hepu Medical Tech will own 70% of the venture after investing 3.2 million yuan, while Sichuan Lindong will own the remaining 30% after investing 1.4 million yuan.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buchang Pharma's Subsidiary to Set Up Joint Venture</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuchang Pharma's Subsidiary to Set Up Joint Venture\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-10 16:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/603858\">Shandong Buchang</a> Pharmaceuticals' (SHA:603858) subsidiary, Shanghai Hepu Medical Technology, agreed to established a joint venture with Sichuan Lindong Enterprise Management Center (Limited Partnership), according to Shanghai bourse filing on Wednesday.</p><p>The joint venture company, Sichuan Hepu Tongchuang Medical Technology, will have a registered capital of 4.5 million yuan</p><p>Hepu Medical Tech will own 70% of the venture after investing 3.2 million yuan, while Sichuan Lindong will own the remaining 30% after investing 1.4 million yuan.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JYNT","symbol_name":"The Joint Corp.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2642441148","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2642441148","pubTimestamp":1781081610,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shandong Buchang Pharmaceuticals'  subsidiary, Shanghai Hepu Medical Technology, agreed to established a joint venture with Sichuan Lindong Enterprise Management Center , according to Shanghai bourse filing on Wednesday.The joint venture company, Sichuan Hepu Tongchuang Medical Technology, will have a registered capital of 4.5 million yuanHepu Medical Tech will own 70% of the venture after investing 3.2 million yuan, while Sichuan Lindong will own the remaining 30% after investing 1.4 million yuan.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"603858":"步长制药","JYNT":"The Joint Corp.","BK0196":"行业龙头","BK4185":"保健护理机构","BK0239":"医药制造"},"translate_title":"步长制药子公司拟成立合资公司","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603858":0.9,"JYNT":1.5},"content_text":"Shandong Buchang Pharmaceuticals' (SHA:603858) subsidiary, Shanghai Hepu Medical Technology, agreed to established a joint venture with Sichuan Lindong Enterprise Management Center (Limited Partnership), according to Shanghai bourse filing on Wednesday.The joint venture company, Sichuan Hepu Tongchuang Medical Technology, will have a registered capital of 4.5 million yuanHepu Medical Tech will own 70% of the venture after investing 3.2 million yuan, while Sichuan Lindong will own the remaining 30% after investing 1.4 million yuan.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}